Bridging Basic Science and Clinical Research
An integral approach
Individual Excellence. Common Success.
The molecular mechanisms of organ damage during systemic inflammation and sepsis are incompletely understood. Importantly, no specific treatment strategy exists to efficiently prevent the development of multi-organ failure during systemic inflammation. The central aim of the Clinical Research Unit CRU342 is the identification and investigation of relevant molecular, immunological and cellular pathways involved in organ dysfunction during systemic inflammation and sepsis, and the identification and investigation of therapeutic treatment strategies.
This will lead to the development of new treatment approaches for patients suffering from systemic inflammatory syndromes and sepsis. The Clinical Research Unit CRU342 comprises projects focusing on different organ systems in the fields of inflammation, cell biology, imaging, microbiology and clinical management of sepsis and organ failure. The CRU342 provides a strong research network combining individual projects investigating different aspects of systemic inflammation and organ dysfunction.
Cooperative Research Network
Immune system dysregulation and endothelial dysfunction are major factors contributing to the deleterious effects of systemic inflammation. We acknowledge this by a comprehensive view on the consequences of this pathological processes on the lung and the kidneys, two of the major organ systems which are most often affected during organ dysfunction following systemic inflammation.
Procalcitonin as a mediator of sepsis-induced endothelial barrier dysfunction
How VE-PTP and Tie-2 regulate endothelial cell junctions in VE-cadherin dependent and independent ways
The role of the alarmin S100A8/A9 and its counter receptor TLR4/MD2 on platelets in the regulation of inflammation, glycocalyx integrity and vascular permeability during inflammation
Exploring the mechanisms of cytokine storm induction and systemic infection by highly pathogenic influenza viruses
The effect of DAMPs and remote ischemic preconditioning on the prevention of acute kidney injury
The role of glutamine in acute kidney injury
Immune system variables in healthy subjects and during systemic inflammation
Effects of hypoalbuminemia on endothelial S1P signaling in sepsis
Effect of Propofol versus sevoflurane on the renoprotective effects of remote ischemic preconditioning (RIPC) in high-risk patients undergoing cardiac surgery
Proteomic-based identification and validation of novel candidate mediators for damage and refurbishment of the endothelial glycocalyx in bacterial sepsis and COVID-19